Prednisone

Synonyms: Adasone,NSC-10023

Prednisone is a synthetic corticosteroid agent that is particularly effective as an immunosuppressant compound.

Prednisone Chemical Structure

Prednisone Chemical Structure

CAS: 53-03-2

Selleck's Prednisone has been cited by 6 publications

Purity & Quality Control

Batch: Purity: 99.91%
99.91

Choose Selective Glucocorticoid Receptor Inhibitors

Biological Activity

Description Prednisone is a synthetic corticosteroid agent that is particularly effective as an immunosuppressant compound.
Targets
Glucocorticoid receptor [1]
In vitro
In vitro Prednisone blocks Peripheral blood lymphocytes (PBL) growth in the G1 phase of cell cycle and inhibits both IL-2 receptor (IL-2R) expression and IL-2 secretion in activated human peripheral blood T lymphocytes. Prednisone increases apoptosis in PHA-activated human PBL, and the apoptotic effect of Prednisone is stronger on CD8(+) than on CD4(+) T lymphocytes. [1]
In Vivo
In vivo Prednisone-treated rats show a significant delay of 20% in learning and memory retention in rats as compared with controls. [2] Prednisone results in reduced weight gain, unchanged alter uterine weight, lowered serum magnesium (Mg), unchange serum calcium (Ca), phosphate (P), 25-hydroxyvitamin D (25OHD), or 1,25-dihydroxyvitamin D [1,25(OH)2D], striking increased in calcified cartilage, reduced cross-sectional area and cortical area, unchange medullary area of the tibial diaphysis, lowered periosteal and endocortical bone formation and apposition rates, increased mean cancellous bone area and cancellous bone perimeter of the tibial metaphysis in both sham-operated and ovariectomized rats. [3] Prednisone-treated rabbit shows a 30% reduction in percent stenosis, a 35% decrease in neointimal area, and a 66% decrement in neointimal thickness. [4] Prednisone treatment significantly reduces the level of TGF-beta1 and HYP in diaphragm from mdx mice to values similar to control mice, but results in a higher level of the HP cross-link compared with untreated mdx mice. [5]
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05669014 Recruiting Idiopathic Inflammatory Myositis Horizon Therapeutics Ireland DAC|Horizon Pharma Ireland Ltd. Dublin Ireland December 4 2023 Phase 2
NCT06037811 Not yet recruiting Inflammatory Arthritis|Immune-related Adverse Event Tom Appleton|Canadian Research Group in Immuno-Oncology|Western University|Lawson Health Research Institute November 2023 Phase 2
NCT06119529 Not yet recruiting Healthy|Atopic Dermatitis Eli Lilly and Company November 1 2023 Phase 1
NCT06079788 Recruiting Nephrotic Syndrome in Children Mao Jianhua|Tongji Hospital|Children''s Hospital affiliated to Capital Institute of Pediatrics|Xinhua Hospital Shanghai Jiao Tong University School of Medicine|Children''s Hospital of Nanjing Medical University|Kunming Children''s Hospital|Yuying Childrens Hospital of Wenzhou Medical University|Ningbo Women & Children''s Hospital|The Children''s Hospital of Zhejiang University School of Medicine November 1 2023 Phase 3
NCT06125405 Recruiting Nephrotic Syndrome in Children|Telitacicept The Children''s Hospital of Zhejiang University School of Medicine November 24 2023 Phase 3

Chemical lnformation & Solubility

Molecular Weight 358.43 Formula

C21H26O5

CAS No. 53-03-2 SDF Download Prednisone SDF
Smiles CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 71 mg/mL ( (198.08 mM); Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Prednisone | Prednisone supplier | purchase Prednisone | Prednisone cost | Prednisone manufacturer | order Prednisone | Prednisone distributor